Research summary
NF-κB transcriptional regulation, retroviral and tumorigenic biology, and post-transcriptional immune control organise this corpus. The 1988 Science paper identified IκB, a 60–70 kDa inhibitor that holds NF-κB in the cytosol of cells not expressing immunoglobulin κ light chain, requiring dissociating agents such as sodium deoxycholate to release NF-κB DNA-binding activity; the fractionated inhibitor inactivated NF-κB from various sources, including nuclei of phorbol-ester-treated cells, in a specific, saturable, and reversible manner, and the cytoplasmic localisation of the NF-κB/IκB complex was supported by enucleation experiments [4]. The 1996 Science paper showed that RelA-deficient mouse fibroblasts and macrophages suffer significantly reduced viability when treated with TNF-α, while RelA+/+ cells are unaffected; cytotoxicity was mediated through TNF receptor 1, and reintroduction of RelA into RelA−/− fibroblasts restored survival, demonstrating an essential role for NF-κB in preventing TNF-α-induced cell death [2]. The 2006 PNAS paper profiled 200 microRNAs in human monocytes and found that miR-146a/b, miR-132, and miR-155 are endotoxin-responsive; promoter analysis identified miR-146a as an NF-κB-dependent gene whose induction by microbial components and pro-inflammatory cytokines positions it as a post-transcriptional negative regulator of innate immune signalling proteins [1]. The 1990 Science paper showed that murine bone marrow infected with a retrovirus encoding the Philadelphia-chromosome-derived P210 bcr/abl protein and transplanted into irradiated syngeneic recipients produced hematologic malignancies including a chronic-myelogenous-leukemia-like myeloproliferative syndrome, providing direct experimental evidence that P210bcr/abl can induce CML in vivo [5]. The 1993 PNAS paper introduced BOSC 23, a transient-transfection 293T-derived ecotropic packaging line that produces >10^6 infectious-unit/ml helper-free retroviral supernatants within 72 hours of CaPO4 transfection, with no detectable replication-competent virus; the system enables high-titre delivery of retroviral vectors carrying genes that are difficult to propagate in stable producer lines [3]. The five works together build a coherent programme connecting transcription-factor regulation [4,2], post-transcriptional regulation by miRNAs in immune signalling [1], experimental retroviral leukemogenesis [5], and the reagent infrastructure that enables high-titre retroviral delivery for gene-transfer experiments [3].
Recent publications
- NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responsesDOI
- An Essential Role for NF-κB in Preventing TNF-α-Induced Cell DeathDOI
- NF-κB: Ten Years AfterDOI
- Multiple nuclear factors interact with the immunoglobulin enhancer sequencesDOI
- A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteinsDOI
- Production of high-titer helper-free retroviruses by transient transfection.DOI
- IκB: a Specific Inhibitor of the NF-κB Transcription FactorDOI
- Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia ChromosomeDOI
- An inducible transcription factor activates expression of human immunodeficiency virus in T cellsDOI
- Viral RNA-dependent DNA Polymerase: RNA-dependent DNA Polymerase in Virions of RNA Tumour VirusesDOI
The lab page does not clearly state student acceptance status. Email the professor directly to confirm.
How to apply
Email David Baltimore 6-12 months before your application deadline. Read several recent papers and reference specific work in your message. Use our how to email a Japanese professor guide for the proven email structure.
For applications via MEXT scholarship: see our MEXT 2027 complete guide and university-specific University Recommendation track.
External profiles
- ORCID: https://orcid.org/0000-0001-8723-8190
- OpenAlex: openalex.org
Profile compiled from public sources (Researchmap, OpenAlex, The University of Tokyo faculty directory). Last refreshed 2026-05. Report incorrect information.